Alamance Regional Joins CDC Funded Infection Reduction Study

December 31, 2012

The Alamance Regional Medical Center (Burlington, find North Carolina) has joined a group of hospitals participating in an infection reduction study using no-touch environmental UV disinfection technology according to a press release.

Tru-D SmartUVC has been selected for the study because of its automated dose-delivery system.

The two year study is sponsored by the CDC.

Alamance Regional Medical Center is a not-for-profit community-based healthcare organization “committed to improving the health of the citizens it serves.” Their vision is, in part, to set the statewide standard for excellence and responsiveness. To help achieve that goal, Alamance Regional began using Tru-D SmartUVC in November to disinfect contact isolation rooms at the hospital.

“For the past three years, hospital-acquired infection (HAI) rates have been dropping at Alamance Regional,” says Sara Wall, RN, Infection Preventionist at Alamance Regional. “This study will help us determine if UV light can help us obtain even lower infection rates.”

According to the press release, nine hospitals are involved in the study.  Four specific pathogens will be studied — MRSA, VRE, C. difficile, and Acinetobacter.

Leave a Comment

Previous post:

Next post: